Glycostem Therapeutics
Biotechnology Research • 
Oss, North Brabant, Netherlands • 21-50 Employees
Company overview
| Headquarters | Kloosterstraat 9, Oss, 5349 AB, NL |
| Phone number | +31412211001 |
| Website | |
| SIC | 283 |
| Founded | 2007 |
| Employees | 21-50 |
| Socials |
Key Contacts at Glycostem Therapeutics
Adil Doganay Duru
Director Of Business Development
Monica Raimo
Director, Product And Process Development
Glycostem Therapeutics Email Formats
Glycostem Therapeutics uses 2 email formats. The most common is {first name} (e.g., john@glycostem.com), used 54.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@glycostem.com | 54.5% |
{first initial} | j@glycostem.com | 45.5% |
About Glycostem Therapeutics
Glycostem Therapeutics is a Dutch biotech company established in 2007. Glycostem Therapeutics has developed the world's first GMP compliant NK cell platform that is ready for industrial scale-up.
Glycostem Therapeutics revenue & valuation
| Annual revenue | $8,300,000 |
| Revenue per employee | $332,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $26,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Glycostem Therapeutics has 11 employees across 6 departments.
Departments
Number of employees
Funding Data
Glycostem Therapeutics has never raised funding before.
Glycostem Therapeutics Tech Stack
Discover the technologies and tools that power Glycostem Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Miscellaneous
CMS
Maps
CDN
SSL/TLS certificate authorities
JavaScript libraries
Webmail
Programming languages
Analytics
United States
Mexico
NorwayFrequently asked questions
4.8
40,000 users
